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ABSTRACT 
Over the past decade extraordinary advances have been made in the study of protozoan parasites. 
Particular progress has occurred in areas such as cultivation of protozoan parasites, immunobiology of 
protozoan parasitic diseases, the biochemistry of protozoa and molecular genetics of these organisms. 
The application of sophisticated culture, monoclonal antibody and recombinant DNA technologies has 
resulted in elucidation of many of the biochemical and molecular bases of such phenomena as antigenic 
variation in African trypanosomas, the autoimmune basis of the pathogenesis of Chagas' disease, 
protective immunity in malaria and parasite evasion of host defense mechanisms. As a result a new 
generation of diagnostic procedures have to provide more accurate detection of protozoan infections and 
thus improved epidemiological information. Vigorous vaccine development efforts are underway which 
will lead to molecularly defined vaccines taylored to specific applications and will provide new weapons 
to combat protozoan diseases. Perhaps most importantly the molecular bases of host-parasite interactions 
are being established and will allow identification of unique biochemical aspects of the biology of 
protozoa thereby revealing appropriate targets for development of vaccines, accurate detection procedures 
and more efficacious chemotherapeutic agents. 
INTRODUCTION 
The term "biotechnology" is frequently 
used in today's literature yet appears to have 
no definition by consensus. Although a 
variety of meanings are apparent, common 
elements embodied in the term biotechnology 
seem to include several recently developed 
biochemical technologies which allow the 
identification, characterization and produc- 
tion of biological macromolecules. this sug- 
gests biotechnology could be broadly defined 
in the context of 4 groups of technologies: 1. 
cell culture, 2. nucleic acid technologies, 3. 
biochemistry (other than nucleic acids, espe- 
cially proteinJpeptide biochemistry), and 4. 
hybridoma/monoclonal antibody (mAb) 
methods. Collectively these could be argued 
to represent the majority of technologies that 
come to mind when we hear the term biotech- 
nology . 
If we consider this collection of tech- 
nologies, then what important issues regard- 
ing parasitic protozoa of animals are being, or 
can be addressed by biotechbology? In a 
general sense, a comprehensive issue being 
addressed is the molecular basis of the host- 
parasite relationship. What are the molecules 
of the host and parasite that participate in this 
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interaction and what are the results of this 
interaction ? Frequently we approach this 
broad issue with the goal of intervention in 
this interaction, often in a very restricted way, 
in order to disrupt the host-parasite interac- 
tions that lead to disease in the host. Clearly 
the development of a vaccine is such an ex- 
ample. In other cases the new fundamental 
knowledge gained by studying a unique fea- 
ture of a particular parasite-host combination 
is a driving force behind some of the inves- 
tigations. The molecular genetics of antigenis 
variation in African trypanosomes has been 
an example of both phenomena. 
With this introduction in mind I would 
like to offer some examples of the application 
of how one or more of these technologies has 
been applied effectively to general problems 
of current interest in the parasitology of 
parasitic protozoa of animals. 
Antigenic Variation-Novel Gene Regula- 
tion and Expression 
African trypanosomes are important 
parasites of domestic livestock in Africa and 
prevent the raising of livestock on much of 
the continent. Antigenic variation in African 
trypanosomes has been known for a long time 
and has recently been recognized in other 
parasitic protozoan species sich as Giardia 
1 lamblia as well. The mechanisms of varia- 
tion have been most extensively studied in 
African trypanosomes where protein 
biochemistry, hybridoma/mAb and recom- 
binant DNA technologies have been applied 
extensively to this problem. Since the initial 
identification and partial analysis of the 
variant-specific surface glycoprotein (VSG) 
2 
as the major variant antigen by Cross a great 
deal of structural and genetic information 
about the VSG, the genes which code for VSG 
and their activation has been published3P'5 
Employing a recombinant DNA approach 
Boothroyd et al obtained the complete se- 
quence of a complementary DNA (cDNA) 
coding for VSG 117. These workers demon- 
strated that the translation product had 
hydrophobic extensions on both the NH2 and 
COOH ends and an unusual glycosylated 
aspartate on the COOH end. 
One of the most striking features of 
African trypanosomes is the presence of 
genes for several VSG's with only one being 
expressed at a time7, except for a very small 
percentage at the time of antigen switching8. 
This is because although multiple VSG genes 
are located on several chromosomes and in 
intrachromosomal as well as telometric sites, 
gene rearrangement mechanisms are neces- 
sary for non-telomeric genes to be ex- 
pressed? Thus in order for a VSG is accom- 
plished for genes outside this site by duplica- 
tive transposition lo to what is termed an 
expression-linked (extra) copy @LC) gene. It 
is the ELC gene in the telometric site 
(transposed or already located here) which is 
then transcribed to give rise to the VSG 
molecule.". 0 ther structural genes for 
VSG's not transcribed. Such duplication (or 
lack of duplication) of basic copy genes to 
ELC was demonstrated by Southern blot 
(DNA-DNA hybridization) analysis of 
genomic trypanosome DNA's from clones 
expressing one VSG. These experiments 
showed that an extra copy a different size was 
present when the DNA was probed with a 
cDNA corresponding to the homologous, ex- 
pressed VSG, but no extra copy was found 
when DNA was probed with a heterologous 
(non-expressed) VSG cDNA. Thus the ability 
to derive cDNA corresponding to the ex- 
pressed VSG (ie, its mRNA) bya recombinant 
DNA methods, was essential to the estab- 
lishment of this system to analyze the 
molecular basis of VSG gene expression. 
The initiation of VSG gene transcription is 
not understood although recent evidence in- 
dicates that expression site-associated, non- 
VSG genes12 and perhaps unusual RNA poly- 
merases13 may be involved, and this process 
is under active investigation. 
A second type of antigenic variation 
has recently been observed in the lumen- 
dwelling protozoan, Giardia lamblia. Earlier 
work had shown that different isolates of 
G. lamblia displayed differences in an- 
tigenic 
Employing an interesting nuclease from 
the mung bean which cleaves segments of 
genomic DNA of protozoans before and after 
genes1s, Adam and colleagues1 prepared a 
genomic library of G.lamblia in gtll and 
selected clones expressing a 170.000 (170k) 
MW surface antigen using antisera specific 
for the 170k antigen. The DNa from this 
vector was subcloned into M13 phage and 
sequenced. This DNA hybridized in Northern 
blots to RNA from G.larnblia clones express- 
ing the 170k antigen did not hybridize to 
clones lacking the 170k. antigen. Using the 
DNA sequence information these authors 
deduced a partial amino acid sequence for the 
170k antigen and determined it contained 
12% cysteine, confirmed by labeling the na- 
tive 170k antigen with 3S~-cysteine. Employ- 
ing different, additional G.lamblia clones and 
two mAbs specific for a 200k MW antigen 
and a 70k M W  antigen, respectively, clones 
were selected from two isolates which ex- 
presed these antigens (or did not express 
them) by growth in the presence of these 
mAbs (ie, antigen deletion mutants)16. These 
results confirmed the variation in expression 
of two additional surface antigens of 
G.lamblia. 
Pathogenesis of Parasitic Protozoa- 
Mechanisms 
The mechanisms of pathogenesis of 
protozoan infections are not well understood 
and until recently presented an almost intrac- 
table problem. With the application of newly 
developed technologies to this problem, how- 
ever, considerable progress is being made in 
understanding the molecular basis of how 
protozoan parasites damage their hosts. 
The pathogenesis of Chagas' disease, a 
prevalent zoonotic disease in Central and 
South America caused by Trypanosoma 
cruzi, has long been thought to be partially 
due to autoimmune responses of the host trig- 
gered somehow by the parasite. The evidence 
has been that 1) mononuclear infiltration of 
cardiac muscle in the abscen-ce of parasites 2) 
antibodies in the sera of patients which 
reacted with normal nerve and muscle tissue 
and 3) mononuclear infiltration and destruc- 
tion of neuronal tissue in the absence of large 
numbers of parasites. 
Two examples of anti-host antibodies 
induced by infection with T.cruzi are now 
well recognized: anti-laminin antibodies and 
antibodies which react with mammalian 
neurones. Early work with serum from 
patients with Chagas' disease showed that 
antibodies reacted with endocaria and vas- 
cular tissues17. Szarfman and colleagues later 
showed that murine laminin was the major 
antigen recognized by the antibodies18 and 
recent data indicate a specificity for murine 
(but not human) laminin in convalescent 
human senun19 suggesting a heterophile an- 
tibody response. 
Autoimmune responses to neuronal tis- 
sues in patients with Chagas' disease have 
been known for some time2'. Wood et a1 
(1982) showed that a murine mAb elicited 
against rat dorsal root ganglia was toxic to 
mammalian neurones in the presence of com- 
plement and reacted with viable amastigotes 
of T.cruzi but not a protective 90k MW an- 
tigen found in epimastigotes2l. Recently an- 
tibodies against acetylcholinesterase have 
been detected in chagasic sera and a mAb 
specific for T.cruzi was shown to react with 
the neuromuscular junc tion of human skeletal 
muscle as well as acetylch~linesterase~~. An 
anti-T.vespertilionis mAb, crossreactive with 
T.cruzi, has also been shown to react with 
sulfated lipids in mammalian brain and 
T.cruzi. These data add support to the autoim- 
mune hypothesis of pathologic changes in 
cardiac and nervous tissue associated with 
chronic Chagas' disease. 
Protozoan parasites which live primarily 
on secretory surfaces are in a somewhat uni- 
que niche and range from being highly 
pathogenic and invasive (eg, Entamoeba his- 
tolytica) to strictly surface-lumen dwelling 
(eg, Giardia lamblia). The mechanisms by 
which this important group of parasitic 
protozoans cause disease are only now being 
clearly established and continue to present 
unique challenges to parasitologists. 
The gut protozoan Entamoeba his- 
tolytica has been long recognized to cause 
tissue damage locally and to be highly in- 
vasive in some instances. How E. histolytica 
causes such tissue damage, however, has only 
recently been addressed in a manner that the 
molecular basis of the pathogenic mechanism 
can begin to be understood. 
The ability to culture E. histolytica 23 
was crucial to obtaining sufficient quantities 
of each of these molecular s ecies to perform 
biochemical anal sis 24p25*2g27 and function- 
al studies 28*29936: The use of biotechnology 
has now allowed a clearer understanding of 
the structural nature and function of these 
molecules. Three entities have been sug- 
gested as integral in the cytopathic me- 
chanism of E. histolytica: a lectin involved in 
adhesion to mammalian cells, thiol proteases 
and a pore-forming molecule termed 
amoebapore3'. The issue of adhesion 
molecules was addressed by Peti  et a127 who 
used mAbs raised against an N-acetyl-D- 
galactosamine-specific lectin of E. histolytica 
to affmity pun@ this lectin, raise additional 
mAbs against it, and purify sufficient quan- 
tities of the lectin to characterize the molecule 
biochemically. They showed that lectin was 
260k MW molecule on non-reducing gels and 
was heterodimer consisting of a 170k and 
35k32. Adherence of amebae to Chinese 
hamster ovary cells could be completely in- 
hibited by mAbs directed against the 170k 
MW subunit thus establishing the functional 
role of this part of the molecule in adherence 
to host cells. Interestingly, mucin binds to this 
lectin and this binding is inhibited by N- 
acetyl-D-galactosamine an oligosaccharide 
moiety of mucin. In the presence of exo- 
genous much adherence and cytotoxicity of 
E. histolytica against rat colonic epithelial 
cells could be inhibited33. 
Adhesion requirements are important in 
the parasite-host cell interaction between 
many other species of protozoan parasites 
including an 83kd MW molecule of 
trypomastigotes of Tripanosoma cruzi which 
binds to heart myoblasts (Lima and villalta 
1980)". laminin-binding proteins in the 
membranes of Trypanosoma vaginalis and 
Tritrichokonas foetus3', mucin-binding lec- 
tin in Tritrichomonas mobilensis (Demes et 
al, 1989. Parasitol Res in press; D.J. Wells 
per cornm), and a modified erythrocyte 
membrane molecule, present in human 
erythrocytes infected with Plasmodium fal- 
ciparum, which may play a role in infected 
erythrocyte adhesion to nucleated cells of '  
blood vessels.36 
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The molecular basis of cytotoxity of 
parasitic protozoans is also being established 
by the application of biotechnological 
methods. With E. histolytica it was well- 
r e c o w  that this parasite can be cytotoxic 
toward mammalian cells 37938*39 and that cell- 
free extracts could mediate this effect4'. 
More recently some of the molecules respon- 
sible for this cytotoxicity have been purified 
and biochemically characterized. Bos et a141 
demonstrated that a partially purified cyto- 
toxin was enhanced by cysteine, inhibited by 
iodoacetate and antibody againts E. his- 
tolyti'ca and secreted into the growth medium. 
In other studies Lushbaugh and colleagues 
purified a 16-20k Mw cytotoxic molecule 
which displayed properties of a cysteine 
proteinase by ion exchange and affinity 
chromatography. The proteinase was revers- 
ibly inhibitable by Pchloromercuribenwate 
if free sulfhydryl groups were present and 
displayed cytotoxic activity in HeLa targets. 
In other studies Youn and colleagues and 
2? Gitler and colleagues purified a lytic factor 
from plasma membrane fractions or whole 
lysates (respectively) of E. histolytica. This 
toxin results in the formation of ion channels 
in target cell membranes and pmed toxin 
molecules of 30k MW and 14k M\ICP2 were 
purified. Differences in function were 
reported for these two lytic molecules in that 
the 30k MW factr lysed rabbit erythrocytes 
while the 14k MW factor did not. 
Protective Antigens-Malaria Vaccine 
Efforts 
A critical development in this regard has 
been the development of culture procedures 
for Plasmodium falciparum and Eimeria 
spp?39**s which allowed growth of the 
erythrocytic and exoerythrocytic of host cells 
by sporozoites and subsequent development 
in vitro. 
Early efforts demonstrated that the 
sporozoite antigens of P. berghei could 
protect mice from challenge with sporo 
zoites 46p7*48. These results suggested an- 
tigens of the sporozoite could be part or per- 
haps the only component of a protective 
vaccine for malaria and stimulated an enor- 
mous amount of work to determine what the 
esential sporowite antigens were for success- 
ful immunization. Later work in which mAbs 
were prepared against a single molecule of 
approximately 44,000 &, the cir- 
cumsporowite (CS) antigen, showed that it 
contained the dominant epitope involved in 
blocking penetration of cells in vitro as well 
as passively protecting mice against chal- 
lenge with Pi berghei qporozoites. Sub- 
sequently the dominant epitope of the CS 
antigen molecule was found to be composed 
of 37 repeats of a tetra tide (ASN-ALA- 
ASN-PRO = NANP)4'< This work was 
facilitated by the discovery by McCutchan et 
alls that mung bean nuclease cleaved 
genornic Plasmodiiun DNA before and after 
genes at sites of naked DNA allowing the 
excision of a complete genomic CS gene and 
its cloning from erythrocytic stages of Pfal- 
ciparwn derived from culhue. Thus culture 
methods, hybridoma and recombinant DNA 
technologies allowed the determination of the 
primary structure of the CS antigen. 
Since the key epitope was a short, repeti- 
tive sequence NANP, synthetic peptides were 
prepared and shown to elicit antibodies in 
mice and rabbits if linked to a protein car- 
riers'. Subsequent work, however, show& 
these responses were restricted to certain 
major histocompatibility haplotypes in the 
mouse 52p53*54 and that variation in the T cell 
epitope of the natural CS protein led to a lack 
of anamnestic response due to a lack of 
crossreactivity between CS roteins from dif- 2s ferent Plasmodium isolates . These results 
raised serious questions as to the feasibility of 
a vaccine composed solely of CS antigen 
components since T cell memory is neces- 
sary. This question together with the need to 
alleviate the requirement of a heterologous 
protein carrier (eg, PPD, vaccinia virus) are 
currently the subject of vigorous research ef- 
forts. 
Parallel investigations have been done 
on the erythrocytic stages of Plasmodium and 
have identified additional antigens with vac- 
cine potential. Experiments employing serum 
from patients with P.  falciparum infections 
have shown that their antibodies recognized 
an antigen of 150.000 MW on the surface of 
infected erythrocytes (from culture)s6 and in- 
hibited merozoite reinvasion of erythrocytes. 
Subsequently the antigen, termed Pf155/ 
RESA, was shown to also contain repetitive 
sequences comprising immunodominant 
human B cell epito es and non-variant T hel- 
per cell epitopes 5T58. reviewed in Troye- 
$4 Blomberg et al, 1988 ). A genomic library 
was used to obtain DNA segments coding for 
the C-terminal end of the Pfl55/RESA an- 
tigen and the combinant polypeptide of PF. 
11.1 was expressed (in gtl 1) and used to elicit 
antibodies. An additional antigen from a 
second, distinct (gene termed 332) has been 
similarly developeds9. These workers have 
shown that when the recombinant polypep- 
tides were used to affinity purify human an- 
tibodies from the sera of P.$alciparum 
patients, the anti-PF 11.1 antibodies reacted 
with 7 antigens, while the anti-332 antibodies 
reacted with 5 antigens, of cultured schizonts 
of P. falciparum. By obtaining the predicted 
amino acid sequence of this antigen from the 
PF 1 1.1 DNA sequence synthetic peptides 
were prepared representing these sequenced 
and the peptide-specific antibodies reacted 
with native P. falciparum schizont antigens 
as well. These results suggest the HI551 
RESA antigen is a second molecule worthy 
of further development as a malaria vaccine 
component. They further indicate a multi- 
valent vaccine is likely to be needed for effec- 
tive prophylaxis against malaria. 
Evasion of Host Defenses-Survival 
Protozoan parasites have evolved many 
ways to evade the defenses of the host or- 
ganism. They can evade natural defenses such 
as barriers like the skin, enzymes such as 
proteases of the mammalian digestive tract 
and the otherwise lethal products of the im- 
mune system. 
One important way parasitic protozoa 
can evade destruction is to in a sheltered 
location such as inside a host cell. In order for 
intracellular protozoan parasites to survive 
and complete their life cycle they must spend 
part of this life cycle inside the host cell(s). 
Members of the Apicomplexa are good ex- 
amples, notably Plasmodium and Eimeria 
species. Both genera produce sporozoites 
which invade nucleated host cells; Plas- 
modium targeting hepatocytes while Eimeria 
invades enterocytes. Thus the molecular basis 
of penetration is a crucial aspect of the biol- 
ogy of genera such as Eimeria and Plas- 
modium. 
Hollingdale and colleagues have shown 
that mAbs directed against the CS antigen of 
sporozoites of P.  falciparum and P .  vivax 
prevented attachment of sporozoites to 
human hepatoma cells in vitro6'). Further 
work indicated that anti-CS mAbs could 
hinder development of sporozoites that did 
manage to penetrate target cells6' indicating 
the mAbs damaged the sporozoites in some 
manner. Similarly, when sporozoites of 
Eimeria bovis are treated with a mAb specific 
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for a 20,000 MW surface antigen, termed 
P20, these sporozoites are prevented from 
penetrating host cells in vitro or hindered in 
their development in vitro. if they manage to 
penetrate63. Employing mRNA-cDNA-ex- 
pression vector strategies Jenkins and col- 
leagues have produced merozoite- and 
sporozoite-derived antigens of E. acervulina 
which were reactive with sera from hyperim- 
munized rabbits64 and a sporozoite antigen 
reactive with an anti-sporozoite mAb which 
identified a 22k MW surface antigen of 
~ ~ o r o z o i t e s ~ ~ .  The recombinant antigen from 
sporozoites, MA1, was also able to stimulate 
avin T cells from chickens immune to E. 
66 acervulina in an in vitro proliferation assay . 
These results indicate the marked effect of 
antibody on parasite stages whichmay not see 
antib~dy in an initial infection of a nonim- 
mune host and give insight into a potential 
point at which the immune response could 
interrupt the life cycle. If, however, the 
sporozoites do avoid contact with the crucial 
antibody they would likely escape destruction 
in this intracellular location since neither 
hepatocytes nor enterocytes are known to 
have any effector function (cf. macrophages). 
In any event these results show that the an- 
tigenic and biological properties of Plas- 
modium and Eimeria spp. are being 
effectively studied at the molecular level and 
these investigations are rapidly providing in- 
sight into the immunology and cell biology of 
these parasites. 
Another method of host defense evasion 
is attachment of host molecules to the surface 
of the parasite, a "cloaking" maneuver. 
This allows the parasite to mask its own 
surface and to present to the host the host's 
own molecules thus being perceived by the 
host as self. Several parasitic protozoa have 
been shown to bind host m o ~ e c u l e s ~ ~ ' ~ ~  or 
possess receptors for host molecules 32.68 
(Demes et a1 1989 Parasitology Research in 
press). While some of these interactions such 
as the attachment of fibronectin to a parasite 
ARG-GLY-ASP-SER sequence22, laminin- 
binding receptors of t r i chom~nads~~ ,  and 
receptors in E. histolytica and trichomonads 
for m ~ c i n ~ ~  (Demes et al Parasitology Re- 
search in press) must function in adhesion of 
the parasite to host surfaces and cells they 
could also allow the parasite to bind free host 
molucules (eg, plasma fibronectin dimers) 
thereby partially masking their surfaces from 
recognition by the host. Similarly suface 
dwelling parasites such as Entamoeba, 
Trichomonas and Tritrichomonas could bind 
molecules such as mucin to avoid recognition 
and attack by host products such as secreted 
proteases. 
SUMMARY 
Considerable effort is being directed at 
establishing the molecular basis of host- 
parasite interactions of protozoan parasites 
and their animal hosts. We have witnessed 
enormous progress in the past 10-15 years in 
our understanding of several of these parasitic 
relationship pet much remains to be done. The 
powerful collection of technologies we term 
biotechnology is rapidly changing as many 
procedures are being automated or replaced 
by faster, more powerful ones. For example 
the combination of the ability to perform 
automated oligonucleotide synthesis coupled 
with the recently developed thermocycling 
polymerase chain reaction synthesis of DNA 
(via Taq polymerase) employing olinu- 
cleotide primers now allows the amplification 
of nanogram quantities of DNA from native 
sources into microgram quantities overnight. 
This makes it possible to effectively study 
genes in low copy numbers, facilitates clon- 
ing of these genes and may allow develop- 
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ment of sensitive and rapid detection methods 
for parasitic infections. 
Sequencing of polypeptides is now 
automated and automated DNA sequencing 
technology will soon be widely available. 
With these technologies we will soon be able 
to obtain the sequences of large areas of the 
genomes of parasitic protozoa which will 
allow us to establish the genetic basis of many 
of their life processes at the molecular level. 
Such knowledge will provide us with the 
tools to develop more effective diagnostic 
procedures and control measures such as 
chemically-defined vaccines and targeted 
chemotherapeutic agents. 
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